Validation in Pharmaceutical Analysis - Live Online Training ICH Q2 Revision, Lifecycle Concept, Precision, and Accuracy

Validation in Pharmaceutical Analysis - Live Online Training

Course No 20982

All times mentioned are CET.
 
All Information on Part 2 "Specificity/Selectivity, Response (Calibration Model), Impurities and Quantitation Limit" can be found here.

Our Service

Costs

ECA-Member*: EUR 590,--
Regular Fee*: EUR 690,--
EU/GMP Inspectorates*: EUR 590,--
APIC Member Discount*: EUR 640,--

(All prices excl. VAT). Important notes on sales tax.

Registration
* also payable by credit card American Express Visa Mastercard

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Dr Joachim Ermer, Ermer Quality Consulting, Germany

Objectives

Besides regulatory expectations, these Live Online Training Courses provide practical recommendations and orientation for demonstration of the on-going suitability of analytical procedures. A rational and efficient validation approach is ultimately based on the respective routine application, which should be reflected in the validation design. This includes the identification of the relevant performance parameters, the selection of appropriate tests and calculations and, in particular, the establishment of acceptance criteria for the evaluation.

Both training courses focus on the relevant performance characteristics, taking the - long-awaited - revision of the ICH Q2 guideline as well as the new Q14 guideline Analytical Procedure development into consideration. Lifecycle aspects will be included in the discussion.

Background

According to EU GMP Guide Part 1, Chapter 6, Quality Control (6.15) and US 21 CFR 211.194, analytical procedures must be suitable for their intended purpose. The regulatory requirements to validation of analytical procedures utilised for release and stability studies of drug substances and drug products are described in the ICH guideline Q2(R1). However, its degree of detail is rather low, and the discussion is mainly focused on chromatographic methods. A broader consideration of other analytical techniques as well as alignment with lifecycle aspects is intended with the revision of Q2. The latter also in the focus of the new ICH Guideline Q14 Analytical Procedure Development and is already content of the USP General Information Chapter <1220> The Analytical Procedure Lifecycle.

Target Group

According to EU GMP Guide Part 1, Chapter 6, Quality Control (6.15) and US 21 CFR 211.194, analytical procedures must be suitable for their intended purpose. The regulatory requirements to validation of analytical procedures utilised for release and stability studies of drug substances and drug products are described in the ICH guideline Q2(R1). However, its degree of detail is rather low, and the discussion is mainly focused on chromatographic methods. A broader consideration of other analytical techniques as well as alignment with lifecycle aspects is intended with the revision of Q2. The latter also in the focus of the new ICH Guideline Q14 Analytical Procedure Development and is already content of the USP General Information Chapter <1220> The Analytical Procedure Lifecycle.

Technical Requirements

We use Webex for our live online training courses and webinars. At www.gmp-compliance.org/training/online-trainingtechnical- information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.

Programme

Lifecycle Concept, ICH Q2 Revision and Q14
  • The Analytical Procedure Lifecycle – USP General Information Chapter <1220> and ICH Q14
  • Overview on important adjustments and complementations in ICH Q2(R2)
  • Reportable range
Analytical Target Profile
  • Requirements to the analytical Performance
  • Error types
  • ATP in Q2(R2) and Q14
  • Evaluation of performance parameters (simple, statistical)
  • Aspects of an efficient validation
Precision
  • Precision levels (system precision, repeatability, intermediate precision, reproducibility)
  • Precision in ICH Q2(R2)
  • Acceptance limits for assay
    - Derivation from probability, measurement uncertainty, tolerance factors
    - Design of precision studies and calculations
    - Uncertainty of precisions: point estimators and confidence intervals
  • Optimisation of precision by averaging (replication strategy)
    - Precision of the reportable value (small molecules,bioassay)
    - Assay for small molecules, bioassay
Accuracy
  • ICH Q2(R2): Comparison, recovery, and technologyinherent justification, combined evaluation of accuracy and precision
  • Statistical significance and equivalence Tests
  • Variability and expected difference between means
  • Acceptance criteria for assay
Workshop: Multiple Choice Questions (from Publications)
  • How to avoid mistakes in validation

Go back

GMP Conferences by Topics